louisiana semaglutide gastroparesis class action Ozempic Lawsuit [2026 Update] The FDA sent a warning
Description
Nearly half of the respondents report intentionally increasing their consumption of fiber (both soluble and insoluble fibers) since starting GLP-1 treatment, said Brad Schwan, vice president of marketing for ADM
Other than the gastrointestinal side effects [11], tirzepatide may rarely contribute to sinus tachycardia, acute kidney injury secondary to dehydration, pancreatitis, cholelithiasis, and cholecystitis
Check the PIL for the complete ingredient list and speak to a pharmacist if you have any allergies
![louisiana semaglutide gastroparesis class action Ozempic Lawsuit [2026 Update] The FDA sent a warning](https://scx2.b-cdn.net/gfx/news/2023/lawsuit-against-makers.jpg)
Legitimate companies have accessible support infrastructure
![louisiana semaglutide gastroparesis class action Ozempic Lawsuit [2026 Update] The FDA sent a warning](https://embed-ssl.wistia.com/deliveries/356b87515b15346280a7124f826d8735.jpg)
Yes, light bruising and minor surface bleeding are normal and not dangerous
![louisiana semaglutide gastroparesis class action Ozempic Lawsuit [2026 Update] The FDA sent a warning](https://www.aboutlawsuits.com/wp-content/uploads/Ozempic-Gastroparesis-Lawsuit-1024x683.jpeg)